Dechert (Philadelphia)

George G. Gordon

Dechert (Philadelphia)
Lawyer (Partner)

George G. Gordon, Co-Leader of the life sciences practice, focuses his practice on antitrust litigation, counseling and government investigations. He is a member of both the antitrust/competition and commercial litigation groups. Mr. Gordon’s experience includes substantial antitrust class action litigation and general antitrust litigation including a number of significant antitrust actions involving claims of monopolization, unlawful price discrimination, unlawful group boycotts, predatory pricing, and monopoly leveraging. He has also successfully represented clients in a number of non-public investigations by the Federal Trade Commission and the Department of Justice, Antitrust Division.

Distinctions

Linked authors

Dechert (Philadelphia)
Dechert (Washington)
Dechert (Washington)
Dechert (Washington)
Dechert (Washington)

Articles

1302 Bulletin

Gregory P. Luib, James A. Fishkin, George G. Gordon The US Supreme Court rules that the FTC does not have authority under Section 13(b) of the FTC Act to seek disgorgement or restitution from defendants (AMG Capital Management)

119

The Supreme Court has ruled that the Federal Trade Commission (FTC) does not have authority under Section 13(b) of the FTC Act to seek disgorgement or restitution from defendants. The agency has increasingly relied on this authority to seek monetary penalties from defendants in antitrust cases, (...)

Steven E. Bizar, Craig G. Falls, George G. Gordon, Shari Ross Lahlou, Thomas J. Miller The US DoJ announces updates to civil investigative demand forms and deposition process

115

The DOJ’s Antitrust Division announced updates late last week to its Civil Investigative Demand (CID) form, explicitly codifying it intent to potentially use materials received in response to CIDs to launch secondary investigations or refer matters to other government enforcement authorities or (...)

Thomas J. Miller, George G. Gordon The US Court of Appeals for the Third Circuit dismisses a complaint only based on past conduct against a pharmaceutical company (Shire Viropharma)

567

On February 25, 2019, the Third Circuit held that the Federal Trade Commission cannot bring litigation in federal court based on past conduct, absent factual allegations demonstrating that a defendant “is violating or is about to violate” the laws enforced by the FTC. In doing so, the court (...)

George G. Gordon, Thomas J. Miller The U.S. Court of Appeals for the Second Circuit affirms a grant of summary judgment in favor of defendants in an old case alleging an unlawful conspiracy in the single-copy magazine industry (Anderson News)

501

The U.S. Court of Appeals for the Second Circuit affirmed a grant of summary judgment on July 19, 2018, in favor of defendants in a nearly decade-old case alleging an unlawful conspiracy in the single-copy magazine industry. The decision clarifies the application of the Supreme Court’s (...)

Send a message